TECH BIO-TECHNE Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: TECH

Price (delayed)

$80.65

Market cap

$12.71B

P/E Ratio

63.5

Dividend/share

$0.32

EPS

$1.27

Enterprise value

$13.06B

Bio-Techne Corporation is a holding company for biotechnology and clinical diagnostic brands. It was founded in 1976 as Techne Corporation and changed its name to Bio-Techne in 2014. The company's ...

Highlights
BIO-TECHNE's equity has increased by 7% YoY and by 2.6% from the previous quarter
The revenue has grown by 2.7% YoY
BIO-TECHNE's debt has decreased by 11% QoQ but it has increased by 4.4% YoY
TECH's EPS is down by 27% year-on-year and by 10% since the previous quarter
The net income has decreased by 25% YoY and by 9% from the previous quarter
Sector: Healthcare
Industry: Biotechnology
Website: https://www.bio-techne.com/
Peers: TMO DHR QGEN BDX

Key stats

What are the main financial stats of TECH
Market
Shares outstanding
157.58M
Market cap
$12.71B
Enterprise value
$13.06B
Valuations
Price to earnings (P/E)
63.5
Price to book (P/B)
6.29
Price to sales (P/S)
10.99
EV/EBIT
53.64
EV/EBITDA
36.89
EV/Sales
11.32
Earnings
Revenue
$1.15B
EBIT
$243.56M
EBITDA
$354.14M
Free cash flow
$251.15M
Per share
EPS
$1.27
Free cash flow per share
$1.6
Book value per share
$12.81
Revenue per share
$7.34
TBVPS
$7.78
Balance sheet
Total assets
$2.72B
Total liabilities
$706.8M
Debt
$494.73M
Equity
$2.01B
Working capital
$460.83M
Liquidity
Debt to equity
0.25
Current ratio
4.08
Quick ratio
2.49
Net debt/EBITDA
1
Margins
EBITDA margin
30.7%
Gross margin
66.8%
Net margin
17.6%
Operating margin
22.1%
Efficiency
Return on assets
7.5%
Return on equity
10.2%
Return on invested capital
16.9%
Return on capital employed
9.5%
Return on sales
21.1%
Dividend
Dividend yield
0.4%
DPS
$0.32
Payout ratio
25.2%

TECH stock price

How has the BIO-TECHNE stock price performed over time
Intraday
2.52%
1 week
6.88%
1 month
11.86%
1 year
-5.1%
YTD
4.52%
QTD
12.56%

Financial performance

How have BIO-TECHNE's revenue and profit performed over time
Revenue
$1.15B
Gross profit
$771.08M
Operating income
$255.39M
Net income
$203M
Gross margin
66.8%
Net margin
17.6%
BIO-TECHNE's net margin has decreased by 27% YoY and by 10% QoQ
The net income has decreased by 25% YoY and by 9% from the previous quarter
BIO-TECHNE's operating margin has decreased by 13% YoY and by 6% QoQ
The company's operating income fell by 10% YoY and by 4.9% QoQ

Growth

What is BIO-TECHNE's growth rate over time

Valuation

What is BIO-TECHNE stock price valuation
TECH P/E details
P/E
63.5
P/B
6.29
P/S
10.99
EV/EBIT
53.64
EV/EBITDA
36.89
EV/Sales
11.32
TECH's EPS is down by 27% year-on-year and by 10% since the previous quarter
TECH's P/E is 25% above its last 4 quarters average of 49.7
The stock's price to book (P/B) is 20% less than its 5-year quarterly average of 7.7 but 4.1% more than its last 4 quarters average of 5.9
BIO-TECHNE's equity has increased by 7% YoY and by 2.6% from the previous quarter
The price to sales (P/S) is 18% lower than the 5-year quarterly average of 13.1 but 5% higher than the last 4 quarters average of 10.2
The revenue has grown by 2.7% YoY

Efficiency

How efficient is BIO-TECHNE business performance
BIO-TECHNE's ROIC has decreased by 48% YoY and by 8% from the previous quarter
TECH's return on assets is down by 34% year-on-year and by 11% since the previous quarter
BIO-TECHNE's return on equity has decreased by 32% YoY and by 11% QoQ
TECH's return on sales is down by 30% year-on-year and by 8% since the previous quarter

Dividends

What is TECH's dividend history
Dividend details
DPS
$0.32
Dividend yield
0.4%
Payout ratio
25.2%
Recent dividends

Financial health

How did BIO-TECHNE financials performed over time
BIO-TECHNE's total liabilities has decreased by 8% QoQ
TECH's current ratio is down by 7% from the previous quarter
BIO-TECHNE's debt is 75% lower than its equity
TECH's debt to equity is down by 11% since the previous quarter
BIO-TECHNE's debt has decreased by 11% QoQ but it has increased by 4.4% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.